Dr. Elizabeth M. Jaffee, the Deputy Director of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, stands at the forefront of pancreatic cancer research. In addition to her significant role in overseeing the cancer center's operations, Dr. Jaffee serves as the Associate Director of the CRI Scientific Advisory Council, contributing her expertise to shape the strategic direction of cancer immunotherapy research. With a focus on pancreatic cancer, Dr. Jaffee's work has been instrumental in advancing our understanding of this challenging disease and exploring innovative therapeutic approaches. Beyond her administrative roles, she actively engages with the scientific community and will be providing viewers with the latest updates and news in the ever-evolving field of immunotherapy. Dr. Jaffee's dedication to advancing pancreatic cancer research and her involvement in shaping immunotherapy's future make her a key figure in the ongoing efforts to combat this formidable disease.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerrese...
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.